Literature DB >> 18154901

Parenteral nutrition-associated cholestasis in small for gestational age infants.

Daniel T Robinson1, Richard A Ehrenkranz.   

Abstract

OBJECTIVE: To identify small for gestational age (SGA) as an independent risk factor for parenteral nutrition-associated cholestasis (PNAC). STUDY
DESIGN: In a case-control study, records of infants treated in the neonatal intensive care unit from 1994 through 2003 with gestational ages (GA) < 34 weeks and exposure to parenteral nutrition (PN) > or = 7 days were reviewed. The primary outcome was the incidence of cholestasis in infants who were SGA. Secondary outcomes included PN duration, age at full enteral nutrition (FEN) and incidence of late-onset sepsis, necrotizing enterocolitis (NEC) and bronchopulmonary dysplasia (BPD). Analysis was by t test, logistic regression, and chi2 analysis.
RESULTS: Cases (n = 79) and control subjects (n = 152) had similar birth weights and GA (963 +/- 465 g versus 1090 +/- 463 g; 27 +/- 2 weeks versus 27 +/- 2 weeks; [mean +/- SD]). Of the infants who were SGA, 58% developed cholestasis (OR = 3.3, P < .01). Infants with cholestasis achieved FEN later (43 +/- 25 days versus 23 +/- 11 days) and had higher rates of sepsis (80% versus 34%), NEC (51% versus 7%), and BPD (65% versus 25%; P < .01). Of infants with cholestasis, infants who were SGA received fewer days of PN than infants who were appropriate for GA (49 +/- 24 days versus 68 +/- 36 days, P = .024).
CONCLUSION: Being SGA is an independent risk factor for PNAC. Infants who are SGA require less PN for cholestasis to develop.

Entities:  

Mesh:

Year:  2007        PMID: 18154901     DOI: 10.1016/j.jpeds.2007.06.002

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  18 in total

1.  Reply.

Authors:  Andreas Repa; Eleonore Pablik
Journal:  J Pediatr       Date:  2019-01-21       Impact factor: 4.406

2.  Liver disease after intensive care of premature baboons: histopathologic observations.

Authors:  Jay Kerecman; Anupamjit Mehrotra; Zachary Goodman
Journal:  J Pediatr Gastroenterol Nutr       Date:  2013-08       Impact factor: 2.839

3.  Intestinal Microbiota, Lipids, and the Pathogenesis of Intestinal Failure-Associated Liver Disease.

Authors:  Way Seah Lee; Ronald J Sokol
Journal:  J Pediatr       Date:  2015-06-27       Impact factor: 4.406

4.  Incidence and Risk Factors of Parenteral Nutrition-Associated Cholestasis in Omani Neonates: Single centre experience.

Authors:  Sharef W Sharef; Siham Al-Sinani; Khalid Al-Naamani; Ibrahim Al-Zakwani; Zenaida S Reyes; Hilal Al-Ryiami; Ashfaq A Khan; Watfa Al-Mamari
Journal:  Sultan Qaboos Univ Med J       Date:  2015-05-28

5.  Short-term intravenous fish oil and pediatric intestinal failure associated liver disease: 3-year follow-up on liver function and nutrition.

Authors:  Kara Calkins; Allison Lowe; Stephen B Shew; James C Y Dunn; Laurie Reyen; Douglas G Farmer; Sherin U Devaskar; Robert Venick
Journal:  J Pediatr Surg       Date:  2013-01       Impact factor: 2.545

6.  Analysis of factors affecting the prognosis of neonatal cholestasis.

Authors:  Pengfei Liu; Lin Guo; Lanfeng Huang; Dewei Zhao; Ruixin Zhen; Xiaoning Hu; Xiaolin Yuan
Journal:  Int J Clin Exp Med       Date:  2015-05-15

7.  Pediatric intestinal failure-associated liver disease is reversed with 6 months of intravenous fish oil.

Authors:  Kara L Calkins; James C Y Dunn; Stephen B Shew; Laurie Reyen; Douglas G Farmer; Sherin U Devaskar; Robert S Venick
Journal:  JPEN J Parenter Enteral Nutr       Date:  2013-07-26       Impact factor: 4.016

Review 8.  Complications associated with parenteral nutrition in the neonate.

Authors:  Kara L Calkins; Robert S Venick; Sherin U Devaskar
Journal:  Clin Perinatol       Date:  2014-06       Impact factor: 3.430

Review 9.  Alternative lipid emulsions versus pure soy oil based lipid emulsions for parenterally fed preterm infants.

Authors:  Vishal Kapoor; Rebecca Glover; Manoj N Malviya
Journal:  Cochrane Database Syst Rev       Date:  2015-12-02

10.  Analysis of mutations of MDR3 exons 9 and 23 in infants with parenteral nutrition-associated cholestasis.

Authors:  Xiu-Fang Yang; Guo-Sheng Liu; Min-Xu Li
Journal:  Exp Ther Med       Date:  2015-10-14       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.